Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Pulmonary Hypertension, May 2018

Free Subscription


Abstracts

Retrieve all available abstracts of the following 61 articles:
HTML format


 

Single Articles

  1. SOLANKI SL, Goyal VK, Baj B
    Reply to 'The link between pulmonary hypertension and adverse renal transplant outcome may be renal venous hypertension'.
    Indian J Anaesth. 2018;62:325.
    Abstract    



  2. GROCOTT HP
    The link between pulmonary hypertension and adverse renal transplant outcome may be renal venous hypertension.
    Indian J Anaesth. 2018;62:324.
    Abstract    



  3. KOBAYASHI H, Kabata R, Kinoshita H, Morimoto T, et al
    EXPRESS: Rare variants in RNF213, a susceptibility gene for moyamoya disease, are found in patients with pulmonary hypertension and aggravate hypoxia-induced pulmonary hypertension in mice.
    Pulm Circ. 2018 Jan 1:2045894018778155. doi: 10.1177/2045894018778155.
    Abstract    



  4. DUARTE JD, Kansal M, Desai AA, Riden K, et al
    Endothelial nitric oxide synthase genotype is associated with pulmonary hypertension severity in left heart failure patients.
    Pulm Circ. 2018;8:2045894018773049.
    Abstract    

    Abstract available

  5. DAS M, Zawada WM, West JD, Stenmark KR, et al
    EXPRESS: JNK2 Regulates Vascular Remodeling in Pulmonary Hypertension.
    Pulm Circ. 2018 Jan 1:2045894018778156. doi: 10.1177/2045894018778156.
    Abstract    



  6. MONDEJAR-PARRENO G, Callejo M, Barreira B, Morales-Cano D, et al
    miR-1 is increased in pulmonary hypertension and downregulates Kv1.5 channels in rat pulmonary arteries.
    J Physiol. 2018 May 2. doi: 10.1113/JP276054.
    Abstract    

    Abstract available

  7. STENMARK KR, Tuder RM
    Peroxisome Proliferator-activated Receptor gamma and Mitochondria: Drivers or Passengers on the Road to Pulmonary Hypertension?
    Am J Respir Cell Mol Biol. 2018;58:555-557.
    Abstract    



  8. SHARMA RK, Oliveira AC, Kim S, Rigatto K, et al
    Involvement of Neuroinflammation in the Pathogenesis of Monocrotaline-Induced Pulmonary Hypertension.
    Hypertension. 2018 Apr 30. pii: HYPERTENSIONAHA.118.10934.
    Abstract    

    Abstract available

  9. COTTINI SR, Brandi G, Pagnamenta A, Weder W, et al
    Pulmonary hypertension is not a risk factor for grade 3 primary graft dysfunction after lung transplantation.
    Clin Transplant. 2018 Apr 6:e13251. doi: 10.1111/ctr.13251.
    Abstract    

    Abstract available

  10. ATWAL D, Ramos JM, Makhoul I
    Late breast cancer recurrence with bone marrow metastases and acute pulmonary hypertension.
    Proc (Bayl Univ Med Cent). 2018;31:213-215.
    Abstract    

    Abstract available

  11. TAWA M, Furukawa T, Tongu H, Sugihara M, et al
    Stimulation of nitric oxide-sensitive soluble guanylate cyclase in monocrotaline-induced pulmonary hypertensive rats.
    Life Sci. 2018 Apr 26. pii: S0024-3205(18)30226.
    Abstract    

    Abstract available

  12. KAMIMURA Y, Okumura N, Adachi S, Shimokata S, et al
    Usefulness of scoring right ventricular function for assessment of prognostic factors in patients with chronic thromboembolic pulmonary hypertension.
    Heart Vessels. 2018 Apr 27. pii: 10.1007/s00380-018-1168.
    Abstract    

    Abstract available

  13. NORAZAH Z, Joyce Darshinee DS
    Progressive pulmonary vein stenosis in Down syndrome infant: a rare cause of pulmonary hypertension.
    Med J Malaysia. 2018;73:119-120.
    Abstract    

    Abstract available

  14. GIANNITSIS E, Mueller-Hennessen M, Katus HA
    Aptamer-based proteomic profiling for prognostication in pulmonary arterial hypertension.
    Lancet Respir Med. 2017 Jun 14. pii: S2213-2600(17)30209.
    Abstract    



  15. REIS A, Santos M, Vicente M, Furtado I, et al
    Health-Related Quality of Life in Pulmonary Hypertension and Its Clinical Correlates: A Cross-Sectional Study.
    Biomed Res Int. 2018;2018:3924517.
    Abstract    

    Abstract available

  16. BAX S, Bredy C, Kempny A, Dimopoulos K, et al
    A stepwise composite echocardiographic score predicts severe pulmonary hypertension in patients with interstitial lung disease.
    ERJ Open Res. 2018;4.
    Abstract    

    Abstract available

  17. INUZUKA R, Hsu S, Tedford RJ, Senzaki H, et al
    Single-Beat Estimation of Right Ventricular Contractility and Its Coupling to Pulmonary Arterial Load in Patients With Pulmonary Hypertension.
    J Am Heart Assoc. 2018;7.
    Abstract    

    Abstract available

  18. SANDNER P, Becker-Pelster EM, Stasch JP
    Discovery and development of sGC stimulators for the treatment of pulmonary hypertension and rare diseases.
    Nitric Oxide. 2018 May 5. pii: S1089-8603(18)30082.
    Abstract    

    Abstract available

  19. FOX RI
    The incidence of pulmonary hypertension is higher in systemic lupus and Sjogren's patients than in scleroderma patients in China.
    Lupus. 2018;27:1051-1052.
    Abstract    



  20. RATHINASABAPATHY A, Bryant AJ, Suzuki T, Moore C, et al
    rhACE2 Therapy Modifies Bleomycin-Induced Pulmonary Hypertension via Rescue of Vascular Remodeling.
    Front Physiol. 2018;9:271.
    Abstract    

    Abstract available

  21. NAKAMOTO T
    Sleep-Disordered Breathing-a Real Therapeutic Target for Hypertension, Pulmonary Hypertension, Ischemic Heart Disease, and Chronic Heart Failure?
    J Nippon Med Sch. 2018;85:70-77.
    Abstract    

    Abstract available

  22. MASCHKE SK, Schoenfeld CO, Kaireit TF, Cebotari S, et al
    MRI-derived Regional Biventricular Function in Patients with Chronic Thromboembolic Pulmonary Hypertension Before and After Pulmonary Endarterectomy.
    Acad Radiol. 2018 May 2. pii: S1076-6332(18)30184.
    Abstract    

    Abstract available

  23. KIZILKAYA MH, Uysal F, Gurbuz E, Taskapilioglu MO, et al
    Atypical presentation of moyamoya disease with pulmonary hypertension: A case report.
    Anatol J Cardiol. 2018;19:350-351.
    Abstract    



  24. KOKKINIDIS DG, Papanastasiou CA, Jonnalagadda AK, Oikonomou EK, et al
    The predictive value of baseline pulmonary hypertension in early and long term cardiac and all-cause mortality after transcatheter aortic valve implantation for patients with severe aortic valve stenosis: A systematic review and meta-analysis.
    Cardiovasc Revasc Med. 2018 Mar 23. pii: S1553-8389(18)30118.
    Abstract    

    Abstract available

  25. BEHR J, Nathan SD, Harari S, Wuyts W, et al
    Sildenafil added to pirfenidone in patients with advanced idiopathic pulmonary fibrosis and risk of pulmonary hypertension: A Phase IIb, randomised, double-blind, placebo-controlled study - Rationale and study design.
    Respir Med. 2018;138:13-20.
    Abstract    

    Abstract available

  26. TIAN SF, Wang HM, Deng JK
    Fatal malignant pertussis with hyperleukocytosis in a Chinese infant: A case report and literature review.
    Medicine (Baltimore). 2018;97:e0549.
    Abstract    

    Abstract available

  27. BUSSOTTI M, Marchese G
    High Altitude Pulmonary Hypertension.
    Cardiovasc Hematol Disord Drug Targets. 2018 May 17. pii: CHDDT-EPUB-90522.
    Abstract    

    Abstract available

  28. DENG H, Zhao S, Yue Y, Liu Y, et al
    IgG4-related disease of pulmonary artery causing pulmonary hypertension.
    Medicine (Baltimore). 2018;97:e10698.
    Abstract    

    Abstract available

  29. SKRIDE A, Sablinskis K, Lejnieks A, Rudzitis A, et al
    Characteristics and Survival Data from Latvian Pulmonary Hypertension Registry: Comparison of Prospective Pulmonary Hypertension Registries in Europe.
    Pulm Circ. 2018 Jan 1:2045894018780521. doi: 10.1177/2045894018780521.
    Abstract    



  30. MASTON LD, Jones DT, Giermakowska W, Howard TA, et al
    EXPRESS: Interleukin-6 Trans-signaling Contributes to Chronic Hypoxia-Induced Pulmonary Hypertension.
    Pulm Circ. 2018 Jan 1:2045894018780734. doi: 10.1177/2045894018780734.
    Abstract    



  31. TANABE N
    Can results from a Japanese pulmonary hypertension registry have an impact on Western guidelines?
    Respir Investig. 2018 Mar 13. pii: S2212-5345(18)30014.
    Abstract    



  32. WANG D, Zhang Z, Yang F, Zhang L, et al
    [Characteristics of Ventricular Function in Pulmonary Hypertension Patients with Different Shape of Interventricular Septum:Preliminary Study with Cardiac Magnetic Resonance Imaging].
    Zhongguo Fei Ai Za Zhi. 2018;21:397-402.
    Abstract    

    Abstract available

  33. BUSE M, Graziano F, Lunetta F, Sulliotti G, et al
    Inhaled nitric oxide as a rescue therapy in a preterm neonate with severe pulmonary hypertension: a case report.
    Ital J Pediatr. 2018;44:55.
    Abstract    

    Abstract available

  34. COLIN GC, Gerber BL, de Meester de Ravenstein C, Byl D, et al
    Pulmonary hypertension due to left heart disease: diagnostic and prognostic value of CT in chronic systolic heart failure.
    Eur Radiol. 2018 May 14. pii: 10.1007/s00330-018-5455.
    Abstract    

    Abstract available

  35. GALHOTRA P, Prabhakar P, Meghwani H, Mohammed SA, et al
    Beneficial effects of fenofibrate in pulmonary hypertension in rats.
    Mol Cell Biochem. 2018 May 14. pii: 10.1007/s11010-018-3355.
    Abstract    

    Abstract available

  36. STEPFFER C, Gaynor E, Lopez M, Gonzalez NE, et al
    [Pulmonary hypertension associated with the human immunodeficiency virus in children: treatment with sildenafil. A case report].
    Arch Argent Pediatr. 2018;116:e437-e441.
    Abstract    

    Abstract available

  37. HANSON SFL, Terry MH, Moretta DT, Power GG, et al
    Inhaled Fasudil Lacks Pulmonary Selectivity in Thromboxane-Induced Acute Pulmonary Hypertension in Newborn Lambs.
    J Cardiovasc Pharmacol Ther. 2018 Jan 1:1074248418772814.
    Abstract    

    Abstract available

  38. RAZA F, Vaidya A, Lacharite-Roberge AS, Lakhter V, et al
    Initial clinical and hemodynamic results of a regional pulmonary thromboendarterectomy program.
    J Cardiovasc Surg (Torino). 2018;59:428-437.
    Abstract    

    Abstract available

  39. RHODES CJ, Wharton J, Ghataorhe P, Watson G, et al
    Plasma proteome analysis in patients with pulmonary arterial hypertension: an observational cohort study.
    Lancet Respir Med. 2017 Jun 14. pii: S2213-2600(17)30161.
    Abstract    

    Abstract available

  40. JAEGER VK, Distler O, Maurer B, Czirjak L, et al
    Functional disability and its predictors in systemic sclerosis: a study from the DeSScipher project within the EUSTAR group.
    Rheumatology (Oxford). 2018;57:441-450.
    Abstract    

    Abstract available

  41. PASCALL E, Tulloh RM
    Pulmonary hypertension in congenital heart disease.
    Future Cardiol. 2018 May 24. doi: 10.2217/fca-2017-0065.
    Abstract    

    Abstract available

  42. GAVILANES-OLEAS FA, Alves JL Jr, Fernandes CJC, Prada LFL, et al
    Use of direct oral anticoagulants for chronic thromboembolic pulmonary hypertension.
    Clinics (Sao Paulo). 2018;73:e216.
    Abstract    

    Abstract available

  43. ALENCAR AKN, Montes GC, Costa DG, Mendes LVP, et al
    Cardioprotection Induced by Activation of GPER in Ovariectomized Rats With Pulmonary Hypertension.
    J Gerontol A Biol Sci Med Sci. 2018 May 21. pii: 5001143.
    Abstract    

    Abstract available

  44. XU J, Wang J, He M, Han H, et al
    Dipeptidyl peptidase IV (DPP-4) inhibition alleviates pulmonary arterial remodeling in experimental pulmonary hypertension.
    Lab Invest. 2018 May 22. pii: 10.1038/s41374-018-0080.
    Abstract    

    Abstract available

  45. LI HP, Xie WM, Huang X, Lu X, et al
    Pulmonary Hypertension in Glycogen Storage Disease Type II.
    Chin Med J (Engl). 2018;131:1375-1376.
    Abstract    



  46. SINGARAYAR CS, Siew Hui F, Cheong N, Swee En G, et al
    Right ventricular dysfunction and pulmonary hypertension: a neglected presentation of thyrotoxicosis.
    Endocrinol Diabetes Metab Case Rep. 2018;2018.
    Abstract    

    Abstract available

  47. ZHANG X, Zhang X, Wang S, Luo J, et al
    Effects of Fasudil on Patients with Pulmonary Hypertension Associated with Left Ventricular Heart Failure with Preserved Ejection Fraction: A Prospective Intervention Study.
    Can Respir J. 2018;2018:3148259.
    Abstract    

    Abstract available

  48. LAWRENCE KM, Hedrick HL, Monk HM, Herkert L, et al
    Treprostinil Improves Persistent Pulmonary Hypertension Associated with Congenital Diaphragmatic Hernia.
    J Pediatr. 2018 May 18. pii: S0022-3476(18)30606.
    Abstract    

    Abstract available

  49. ZHOU Y, Tian X, Wang X, Wang Y, et al
    Quaternary ammonium salt of U50,488H elicits protective effects against hypoxic pulmonary hypertension.
    Eur J Pharmacol. 2018 May 18. pii: S0014-2999(18)30288.
    Abstract    

    Abstract available

  50. CHERNYAVSKIY AM, Edemskiy AG, Novikova NV, Romanov AB, et al
    [Radiofrequency Pulmonary Artery Ablation for Treatment of Residual Pulmonary Hypertension After Pulmonary Endarterectomy].
    Kardiologiia. 2018;:15-21.
    Abstract    

    Abstract available

  51. LA ROVERE MT, Fanfulla F, Taurino AE, Bruschi C, et al
    Chronic thromboembolic pulmonary hypertension: Reversal of pulmonary hypertension but not sleep disordered breathing following pulmonary endarterectomy.
    Int J Cardiol. 2018;264:147-152.
    Abstract    

    Abstract available

  52. HUTCHINSON JC, Fulcher JW, Hanna J, Ward ME, et al
    Pulmonary Tumor Thrombotic Microangiopathy: Case Report and Review of Literature.
    Am J Forensic Med Pathol. 2018;39:56-60.
    Abstract    

    Abstract available

  53. VAN DER FEEN DE, Bartelds B, de Boer RA, Berger RM, et al
    Pulmonary arterial hypertension in congenital heart disease: translational opportunities to study the reversibility of pulmonary vascular disease.
    Eur Heart J. 2017 Feb 23. doi: 10.1093.
    Abstract    

    Abstract available

  54. GONCHAROV DA, Goncharova EA, Tofovic SP, Hu J, et al
    Metformin Therapy for Pulmonary Hypertension Associated with HFpEF versus PAH.
    Am J Respir Crit Care Med. 2018 May 4. doi: 10.1164/rccm.201801-0022.
    Abstract    



  55. TANIGUCHI Y, Brenot P, Jais X, Garcia C, et al
    Poor Subpleural Perfusion Predicts Failure after Balloon Pulmonary Angioplasty for non-operable Chronic Thromboembolic Pulmonary Hypertension.
    Chest. 2018 May 3. pii: S0012-3692(18)30659-7. doi: 10.1016/j.chest.2018.
    Abstract    

    Abstract available

  56. KOLSTAD KD, Li S, Steen V, Chung L, et al
    Long-term Outcomes in Systemic Sclerosis Associated Pulmonary Arterial Hypertension from the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma Registry (PHAROS).
    Chest. 2018 May 16. pii: S0012-3692(18)30736-0. doi: 10.1016/j.chest.2018.
    Abstract    

    Abstract available

  57. KING CS, Brown AW, Shlobin OA, Weir N, et al
    Prevalence and Impact of WHO Group 3 Pulmonary Hypertension in Advanced Idiopathic Nonspecific Interstitial Pneumonia.
    Eur Respir J. 2018 May 17. pii: 13993003.00545-2018.
    Abstract    



  58. PRABHU MA, Ismael S, Remani K, Nair R, et al
    Association of Transforming Growth Factor-beta Superfamily Genes with Non-Regression of Pulmonary Artery Hypertension Following Balloon Mitral Valvotomy: A Pilot Study.
    J Heart Valve Dis. 2016;25:708-715.
    Abstract    

    Abstract available

  59. BENTSEN MH, Satrell E, Reigstad H, Johnsen SL, et al
    Mid-childhood outcomes after pre-viable preterm premature rupture of membranes.
    J Perinatol. 2017 Jun 29. doi: 10.1038/jp.2017.
    Abstract    

    Abstract available

  60. JACKSON W, Hornik CP, Messina JA, Guglielmo K, et al
    In-hospital outcomes of premature infants with severe bronchopulmonary dysplasia.
    J Perinatol. 2017 Apr 6. doi: 10.1038/jp.2017.
    Abstract    

    Abstract available

  61. LAUNAY D, Montani D, Hassoun PM, Cottin V, et al
    Clinical phenotypes and survival of pre-capillary pulmonary hypertension in systemic sclerosis.
    PLoS One. 2018;13:e0197112.
    Abstract    

    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;